BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 35655404)

  • 41. Chromosomal gains and losses in primary colorectal carcinomas detected by CGH and their associations with tumour DNA ploidy, genotypes and phenotypes.
    De Angelis PM; Clausen OP; Schjølberg A; Stokke T
    Br J Cancer; 1999 May; 80(3-4):526-35. PubMed ID: 10408863
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Lower incidence of colorectal cancer and later age of disease onset in 27 families with pathogenic MSH6 germline mutations compared with families with MLH1 or MSH2 mutations: the German Hereditary Nonpolyposis Colorectal Cancer Consortium.
    Plaschke J; Engel C; Krüger S; Holinski-Feder E; Pagenstecher C; Mangold E; Moeslein G; Schulmann K; Gebert J; von Knebel Doeberitz M; Rüschoff J; Loeffler M; Schackert HK
    J Clin Oncol; 2004 Nov; 22(22):4486-94. PubMed ID: 15483016
    [TBL] [Abstract][Full Text] [Related]  

  • 43. So-called "inflammatory leiomyosarcoma'': a series of 3 cases providing additional insights into a rare entity.
    Chang A; Schuetze SM; Conrad EU; Swisshelm KL; Norwood TH; Rubin BP
    Int J Surg Pathol; 2005 Apr; 13(2):185-95. PubMed ID: 15864383
    [TBL] [Abstract][Full Text] [Related]  

  • 44. DNA sequence copy number aberrations associated with histological subtypes and DNA ploidy in gastric carcinoma.
    Kong G; Oga A; Park CK; Kawauchi S; Furuya T; Sasaki K
    Jpn J Cancer Res; 2001 Jul; 92(7):740-7. PubMed ID: 11473724
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Genetic testing for hereditary nonpolyposis colorectal cancer.
    Hoedema R; Monroe T; Bos C; Palmer S; Kim D; Marvin M; Luchtefeld M
    Am Surg; 2003 May; 69(5):387-91; discussion 391-2. PubMed ID: 12769209
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Immunohistochemistry as first-line screening for detecting colorectal cancer patients at risk for hereditary nonpolyposis colorectal cancer syndrome: a 2-antibody panel may be as predictive as a 4-antibody panel.
    Shia J; Tang LH; Vakiani E; Guillem JG; Stadler ZK; Soslow RA; Katabi N; Weiser MR; Paty PB; Temple LK; Nash GM; Wong WD; Offit K; Klimstra DS
    Am J Surg Pathol; 2009 Nov; 33(11):1639-45. PubMed ID: 19701074
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Soft tissue sarcoma and the hereditary non-polyposis colorectal cancer (HNPCC) syndrome: formulation of an hypothesis.
    Urso E; Agostini M; Pucciarelli S; Bedin C; D'angelo E; Mescoli C; Viel A; Maretto I; Mammi I; Nitti D
    Mol Biol Rep; 2012 Oct; 39(10):9307-10. PubMed ID: 22782591
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Compound heterozygosity for two MSH6 mutations in a patient with early onset colorectal cancer, vitiligo and systemic lupus erythematosus.
    Rahner N; Höefler G; Högenauer C; Lackner C; Steinke V; Sengteller M; Friedl W; Aretz S; Propping P; Mangold E; Walldorf C
    Am J Med Genet A; 2008 May; 146A(10):1314-9. PubMed ID: 18409202
    [TBL] [Abstract][Full Text] [Related]  

  • 49. MLH1 promoter germline-methylation in selected probands of Chinese hereditary non-polyposis colorectal cancer families.
    Zhou HH; Yan SY; Zhou XY; Du X; Zhang TM; Cai X; Lu YM; Cai SJ; Shi DR
    World J Gastroenterol; 2008 Dec; 14(48):7329-34. PubMed ID: 19109866
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Smooth muscle neoplasms of the urinary bladder: a clinicopathologic comparison of leiomyoma and leiomyosarcoma.
    Martin SA; Sears DL; Sebo TJ; Lohse CM; Cheville JC
    Am J Surg Pathol; 2002 Mar; 26(3):292-300. PubMed ID: 11859200
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Identification and characterization of a novel MLH1 genomic rearrangement as the cause of HNPCC in a Tunisian family: evidence for a homologous Alu-mediated recombination.
    Aissi-Ben Moussa S; Moussa A; Lovecchio T; Kourda N; Najjar T; Ben Jilani S; El Gaaied A; Porchet N; Manai M; Buisine MP
    Fam Cancer; 2009; 8(2):119-26. PubMed ID: 18792805
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Lynch syndrome (hereditary nonpolyposis colorectal cancer) diagnostics.
    Lagerstedt Robinson K; Liu T; Vandrovcova J; Halvarsson B; Clendenning M; Frebourg T; Papadopoulos N; Kinzler KW; Vogelstein B; Peltomäki P; Kolodner RD; Nilbert M; Lindblom A
    J Natl Cancer Inst; 2007 Feb; 99(4):291-9. PubMed ID: 17312306
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Extended microsatellite analysis in microsatellite stable, MSH2 and MLH1 mutation-negative HNPCC patients: genetic reclassification and correlation with clinical features.
    Schiemann U; Müller-Koch Y; Gross M; Daum J; Lohse P; Baretton G; Muders M; Mussack T; Kopp R; Holinski-Feder E
    Digestion; 2004; 69(3):166-76. PubMed ID: 15118395
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Genetic testing for hereditary nonpolyposis colorectal cancer (HNPCC).
    Hegde MR; Roa BB
    Curr Protoc Hum Genet; 2009 Apr; Chapter 10():Unit 10.12. PubMed ID: 19360696
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Leiomyosarcoma of the breast: a pathologic and comparative genomic hybridization study of two cases.
    Lee J; Li S; Torbenson M; Liu QZ; Lind S; Mulvihill JJ; Bane B; Wang J
    Cancer Genet Cytogenet; 2004 Feb; 149(1):53-7. PubMed ID: 15104283
    [TBL] [Abstract][Full Text] [Related]  

  • 56. ARID1A deficient undifferentiated spindle cell and rhabdoid sarcoma of the prostate: report of a unique case with emphasis on diagnostic implications.
    Xu W; Dong H; Ru G; Zhao M
    Diagn Pathol; 2022 Feb; 17(1):22. PubMed ID: 35125107
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Genomic aberrations in carcinomas of the uterine corpus.
    Micci F; Teixeira MR; Haugom L; Kristensen G; Abeler VM; Heim S
    Genes Chromosomes Cancer; 2004 Jul; 40(3):229-46. PubMed ID: 15139002
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Cytogenetic abnormalities in primary bronchopulmonary leiomyosarcoma of childhood.
    Schneider BF; Lovell MA; Golden WL
    Cancer Genet Cytogenet; 1998 Sep; 105(2):145-51. PubMed ID: 9723032
    [TBL] [Abstract][Full Text] [Related]  

  • 59. BRAF-V600E is not involved in the colorectal tumorigenesis of HNPCC in patients with functional MLH1 and MSH2 genes.
    Domingo E; Niessen RC; Oliveira C; Alhopuro P; Moutinho C; Espín E; Armengol M; Sijmons RH; Kleibeuker JH; Seruca R; Aaltonen LA; Imai K; Yamamoto H; Schwartz S; Hofstra RM
    Oncogene; 2005 Jun; 24(24):3995-8. PubMed ID: 15782118
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Genomic Alterations in Undifferentiated Malignant Tumors with Rhabdoid Phenotype and Loss of BRG1 Immunoexpression Identified by Fine Needle Aspirates.
    Mei L; Alikhan M; Mujacic I; Parilla M; Antic T
    Acta Cytol; 2019; 63(5):438-444. PubMed ID: 31230044
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.